KAIST researchers identify mechanism that fuels a 'domino effect' in cancer drug resistance

KAIST researchers identify mechanism that fuels a 'domino effect' in cancer drug resistance

KAIST researchers identify mechanism that fuels a 'domino effect' in cancer drug resistance

KAIST researchers have identified mechanisms that relay prior acquired resistance to the first-line chemotherapy to the second-line targeted therapy, fueling a "domino effect" in cancer drug resistance.